Instrument Inactif

Autres langues Wuhan General Group (China), Inc. Other OTC

Actions

WUHN

US9825691051

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

M2Bio Sciences Pharmacology and Clinical Application of CBD	18/09/23
Institute of Biomedical Research Corp. Appoints Adrian J. Maizey to Advisory Board of M2Bio Sciences	19/07/23
Wuhan General China : Announces Disposal	18/07/22
Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN).	18/07/22
Wuhan General China : Annual disclosure and Financial Statements	30/03/22
Wuhan General Group, Inc. reached an agreement to acquire a 40% stake in Tsime Pharmaceuticals Ltd from Bataung Likate and other shareholders.	08/12/21
Wuhan General (China) : Quarterly Report 30 September 2021	22/11/21
Wuhan General (China) : Quarterly Report 30 September 2021	19/11/21
Wuhan General China : Group, Inc.	21/07/21
Wuhan General Group, Inc. Announces Appointment of Michael Sachar as CEO of M2bio Sciences Food &Beverage	20/05/21
Wuhan General Group, Inc. announced that it expects to receive $0.45 million in funding from ThreeD Capital Inc.	30/12/20
CORRECTING and REPLACING – Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com	22/05/20
Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com	22/05/20
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa	07/11/19
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa	07/11/19
Wuhan General Group Appoints Distinguished Scientist Dr. Hyder A. Khoja as Chief Scientific Officer	15/08/19
Wuhan General Group Appoints Hyder A. Khoja as Chief Scientific Officer	15/08/19
Wuhan General Group, Inc. Announces Strategic Reorganization to Capitalize Medical Marijuana and Psilocybin Mushroom Industries; Appoints Luka Marjanovic as Head of Product Development for the MJ MedTech Division in South Africa	07/08/19
Wuhan Provides Updates on Corporate, Psilocybin and Cannabis Q3 2019 Milestones	02/07/19
Wuhan Expands Capacity to Produce Medicinal Marijuana and Mushrooms	17/05/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Wuhan General Group (China), Inc. Other OTC

Actions

WUHN

US9825691051

Autres langues

Filtres